The9 Limited’s Investee Nanyang Biologics Advances Planned Nasdaq Listing in US$1.5 Billion Business Combination
August 11, 2026
The9 Limited said its Singapore investee Nanyang Biologics Pte. Ltd. (NYB) received notice of effectiveness from the U.S. SEC for its Form F-4 registration statement tied to a previously announced business combination valued at about US$1.5 billion. The listing is planned on Nasdaq (ticker symbol “NYB”), subject to NYB’s SPAC extraordinary general meeting and Nasdaq approval.
- Buyers
- The9 Limited, Gamenow.net (Hong Kong) Limited
- Targets
- Nanyang Biologics Pte. Ltd.
- Industry
- AI & Machine Learning
- Location
- Singapore
- Transaction Type
- Growth capital
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.